Literature DB >> 113217

Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans.

J Trap-Jensen, J E Carlsen, T L Svendsen, N J Christensen.   

Abstract

The cardiovascular and adrenergic responses to cigarette smoking during acute selective and non-selective beta adrenoceptor blockade were studied in seven young healthy volunteers in a double blind cross-over fashion. Heart rate, arterial blood pressure, forearm blood flow and plasma levels of adrenaline and noradrenaline were determined before and during the terminal 5 min period of 15 min smoking test. During smoking, plasma concentrations of adrenaline increased markedly and evenly by approximately 0.3 ng/ml in all three experimental sessions. Plasma concentrations of noradrenaline remained unchanged. Propranolol, a non-selective beta blocker, caused a marked rise in diastolic and mean blood pressure and forearm vascular resistance during smoking. This response was not seen in the control series or after selective beta-1 blockage with atenolol. This difference is attributable to propranolol's blockade of adrenaline's vasodilating effect mediated by beta-2 receptors in the resistance vessels. Furthermore, atenolol attenuated the systolic blood pressure and tachycardiac responses induced by cigarette smoking by comparison with placebo. This study suggests that selective beta-1 blockers are preferable in the management of patients who are habitual smokers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 113217     DOI: 10.1111/j.1365-2362.1979.tb00920.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

Review 1.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

2.  Changes in muscle blood flow after smoking a cigarette determined by a new noninvasive method.

Authors:  F Weber; M Anlauf; R D Müller
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  The cardiovascular effects of nicotine during stress.

Authors:  K A Perkins; L H Epstein; J R Jennings; R Stiller
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Peripheral haemodynamic effects of smoking in habitual smokers. A methodological study.

Authors:  I Berlin; A Cournot; P Renout; J Duchier; M Safar
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Augmented vasoconstrictor response to head-up tilt in peripheral tissues during beta-receptor blockade.

Authors:  K Skagen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Haemodynamic effects of cigarette smoking during chronic selective and non-selective beta-adrenoceptor blockade in patients with hypertension.

Authors:  H Houben; T Thien; A Van 'T Laar
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

Review 7.  The large studies in hypertension: what have they shown?

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

8.  A survey on blood pressure levels and hypertension control in a sample of the Italian general population.

Authors:  Marco De Giusti; Eleonora Dito; Beniamino Pagliaro; Simone Burocchi; Flora Ilaria Laurino; Giuliano Tocci; Massimo Volpe; Speranza Rubattu
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-09-01

Review 9.  Management of the hypertensive patient who smokes.

Authors:  H Pardell; R Tresserras; E Saltó; P Armario; R Hernández
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

Review 10.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.